Literature DB >> 21480328

Impact of radiation and hepatitis virus infection on risk of hepatocellular carcinoma.

Waka Ohishi1, Saeko Fujiwara, John B Cologne, Gen Suzuki, Masazumi Akahoshi, Nobuo Nishi, Masataka Tsuge, Kazuaki Chayama.   

Abstract

UNLABELLED: In cohort studies of atomic bomb survivors and Mayak nuclear facility workers, radiation-associated increases in liver cancer risk were observed, but hepatitis B virus (HBV) and hepatitis C virus (HCV) infections were not taken strictly into account. We identified 359 hepatocellular carcinoma (HCC) cases between 1970 and 2002 in the cohort of atomic bomb survivors and estimated cumulative incidence of HCC by radiation dose. To investigate contributions of radiation exposure and hepatitis virus infection to HCC risk, we conducted a nested case-control study using sera stored before HCC diagnosis in the longitudinal cohort of atomic bomb survivors. The study included 224 HCC cases and 644 controls that were matched to the cases on gender, age, city, and time and method of serum storage, and countermatched on radiation dose. The cumulative incidence of HCC by follow-up time and age increased significantly with radiation dose. The relative risk (RR) of HCC for radiation at 1 Gy was 1.67 (95% confidence interval: 1.22-2.35) with adjustment for alcohol consumption, body mass index (BMI), and smoking habit, whereas the RRs for HBV or HCV infection alone were 63 (20-241) and 83 (36-231) with such adjustment, respectively. Those estimates changed little when radiation and hepatitis virus infection were fit simultaneously. The RR of non-B, non-C HCC at 1 Gy was 1.90 (1.02-3.92) without adjustment for alcohol consumption, BMI, or smoking habit and 2.74 (1.26-7.04) with such adjustment.
CONCLUSION: These results indicate that radiation exposure and HBV and HCV infection are associated independently with increased HCC risk. In particular, radiation exposure was a significant risk factor for non-B, non-C HCC with no apparent confounding by alcohol consumption, BMI, or smoking habit. 2011 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2011        PMID: 21480328     DOI: 10.1002/hep.24207

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  6 in total

1.  Assessing liver proteins and enzymes of medical workers exposed to ionizing radiation (IR).

Authors:  Saman Shahid; Khalid Masood
Journal:  Clin Exp Med       Date:  2017-05-10       Impact factor: 3.984

2.  Serum HBV RNA and HBeAg are useful markers for the safe discontinuation of nucleotide analogue treatments in chronic hepatitis B patients.

Authors:  Masataka Tsuge; Eisuke Murakami; Michio Imamura; Hiromi Abe; Daiki Miki; Nobuhiko Hiraga; Shoichi Takahashi; Hidenori Ochi; C Nelson Hayes; Hiroyuki Ginba; Kazuhiro Matsuyama; Hiroiku Kawakami; Kazuaki Chayama
Journal:  J Gastroenterol       Date:  2013-02-09       Impact factor: 7.527

3.  Lack of Knowledge About Hepatitis C Infection Rates Among Patients With Inherited Coagulation Disorders in Countries Under the Eastern Mediterranean Region Office of WHO (EMRO): A Meta-Analysis.

Authors:  Seyed Moayed Alavian; Seyed Hossein Aalaei-Andabili
Journal:  Hepat Mon       Date:  2012-04-30       Impact factor: 0.660

4.  Fish intake and risk of liver cancer: a meta-analysis.

Authors:  Rui-Xue Huang; Yan-Ying Duan; Jian-An Hu
Journal:  PLoS One       Date:  2015-01-23       Impact factor: 3.240

5.  Comparison of hepatocellular carcinoma (HCC), cholangiocarcinoma (CC), and combined HCC-CC (CHC) with each other based on microarray dataset.

Authors:  Lishan Wang
Journal:  Tumour Biol       Date:  2013-03-27

6.  Total Flavonoids from Oroxylum indicum Induce Apoptosis via PI3K/Akt/PTEN Signaling Pathway in Liver Cancer.

Authors:  Nan-Nan Li; Xian-Sheng Meng; Wen-Xiao Men; Yong-Rui Bao; Shuai Wang
Journal:  Evid Based Complement Alternat Med       Date:  2018-02-15       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.